M. Jaber et al., Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter, EUR J NEURO, 11(10), 1999, pp. 3499-3511
Mice lacking the dopamine transporter (DAT) display biochemical and behavio
ural dopaminergic hyperactivity despite dramatic alteration in dopamine hom
eostasis. In order to determine the anatomical and functional integrity of
the dopaminergic system, we examined the expression of tyrosine hydroxylase
(TH), the rate-limiting enzyme of dopamine synthesis as well as DOPA decar
boxylase and vesicular monoamine transporter. TH-positive neurons in the su
bstantia nigra were only slightly decreased (-27.6+/-4.5%), which can not a
ccount for the dramatic decreases in the levels of TH and dopamine that we
previously observed in the striatum. TH mRNA levels were decreased by 25% i
n the ventral midbrain with no modification in the ratio of TH mRNA levels
per cell. However, TH protein levels were decreased by 90% in the striatum
and 35% in the ventral midbrain. In the striatum, many dopaminergic project
ions had no detectable TH, while few projections maintained regular labelli
ng as demonstrated using electron microscopy. DOPA decarboxylase levels wer
e not modified an vesicular transporter levels were decreased by only 28.7%
which suggests that the loss of TH labelling in the striatum is not due to
loss of TH projections. Interestingly, we also observed sporadic TH-positi
ve cell bodies using immunohistochemistry and in situ hybridization in the
striatum of homozygote mice, and to some extent that of wild-type animals,
which raises interesting possibilities as to their potential contribution t
o the dopamine hyperactivity and volume transmission previously reported in
these animal. In conjunction with out previous findings, these results hig
hlight the complex regulatory mechanisms controlling TH expression at the l
evel of mRNA, protein, activity and distribution. The paradoxical hyperdopa
minergia in the DAT KO mice despite a marked decrease in TH and dopamine le
vels suggests a parallel to Parkinson's disease implying that blockade of D
AT may be beneficial in this condition.